At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02228 XTALPI
Trading 10-14 13:35:29
6.430
-0.040
-0.62%
High6.490Low6.380Vol25.59M
Open6.470D1 Closing6.470Amplitude1.70%
Mkt Cap27.66BTradable Cap27.66BTotal Shares4.30B
T/O164.36MT/O Rate0.59%Tradable Shares4.30B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Board Chairman Wen Shuhao Increases Stake in XTALPI by 993,000 Shares at Approximately HK$6.89 Each
Stock News  ·  10-13 20:11
Board Chairman Wen Shuhao Increases Stake in XTALPI by 993,000 Shares at Approximately HK$6.89 Each
Ailux Appoints Lloyd S. Miller, M.d., Ph.d., as Chief Medical Officer
THOMSON REUTERS  ·  10-13 20:00
Ailux Appoints Lloyd S. Miller, M.d., Ph.d., as Chief Medical Officer
Movement Alert｜XTALPI Intraday Decline 5.08%, AI Pharma Sector Slumps After Holiday Rally
Market Focus  ·  10-13 09:38
Movement Alert｜XTALPI Intraday Decline 5.08%, AI Pharma Sector Slumps After Holiday Rally
Movement Alert｜XTALPI Falls 5.04% in Regular Trading, Innovation Drug Sector Pullback Weighs on Shares
Market Focus  ·  10-09
Movement Alert｜XTALPI Falls 5.04% in Regular Trading, Innovation Drug Sector Pullback Weighs on Shares
XTALPI: Shu Hao Wen Acquires Shares, Long Position Rises to 15.82%
HK Disclosure  ·  10-08
XTALPI: Shu Hao Wen Acquires Shares, Long Position Rises to 15.82%
XtalPi Chairman Boosts Stake
MT Newswires Live  ·  10-08
XtalPi Chairman Boosts Stake
XtalPi Reports Chairman Wen Shuhao Purchases 1.3 Million Shares on Oct 7
Reuters  ·  10-07
XtalPi Reports Chairman Wen Shuhao Purchases 1.3 Million Shares on Oct 7
XTALPI Chairman Acquires 1.30 Million Shares for HK$9.50 Million in First Tranche of Stake-Building Plan
Bulletin Express  ·  10-07
XTALPI Chairman Acquires 1.30 Million Shares for HK$9.50 Million in First Tranche of Stake-Building Plan
Xtalpi - Chairman DR. Wen Shuhao Purchases 1.3 Mln Shares for Hk$9.5 Mln
THOMSON REUTERS  ·  10-07
Xtalpi - Chairman DR. Wen Shuhao Purchases 1.3 Mln Shares for Hk$9.5 Mln
Movement Alert｜XTALPI Falls 6.56% in Regular Trading, Innovative Drug Sector Retreat Weighs on Sentiment
Market Focus  ·  10-07
Movement Alert｜XTALPI Falls 6.56% in Regular Trading, Innovative Drug Sector Retreat Weighs on Sentiment
Why XtalPi Holdings (SEHK:2228) Is Up 5.9% And What's Next
Simply Wall St.  ·  10-07
Why XtalPi Holdings (SEHK:2228) Is Up 5.9% And What's Next
XTALPI Trims Outstanding Shares by 2.29 Million in September; Continues Buy-backs and Grants New Options
Bulletin Express  ·  10-06
XTALPI Trims Outstanding Shares by 2.29 Million in September; Continues Buy-backs and Grants New Options
XTALPI Shares Rise Over 5% in Morning Trading as Hair Loss Pipeline Enters IND-Enabling Stage
Deep News  ·  10-06
XTALPI Shares Rise Over 5% in Morning Trading as Hair Loss Pipeline Enters IND-Enabling Stage
Movement Alert｜XTALPI Intraday Rise 5.36%, Innovation Pharma Momentum Builds Ahead of ESMO
Market Focus  ·  10-06
Movement Alert｜XTALPI Intraday Rise 5.36%, Innovation Pharma Momentum Builds Ahead of ESMO
XtalPi buys back 2.00 million shares for HK $15.69 million; cumulative repurchases reach 6.72 million shares
Bulletin Express  ·  10-05
XtalPi buys back 2.00 million shares for HK $15.69 million; cumulative repurchases reach 6.72 million shares
XTALPI Spends HK$15.6929 Million to Buy Back 2.004 Million Shares on October 5
Stock News  ·  10-05
XTALPI Spends HK$15.6929 Million to Buy Back 2.004 Million Shares on October 5
Xtalpi - Advances Hair Loss Drug Program into Ind-Enabling Studies
THOMSON REUTERS  ·  10-03
Xtalpi - Advances Hair Loss Drug Program into Ind-Enabling Studies
XtalPi Advances Hair Loss Drug Program into IND-Enabling Studies
Reuters  ·  10-03
XtalPi Advances Hair Loss Drug Program into IND-Enabling Studies
XtalPi, Fangda Carbon Deploy AI Model to Optimize Graphite Electrode Formulations
Reuters  ·  10-02
XtalPi, Fangda Carbon Deploy AI Model to Optimize Graphite Electrode Formulations
XTALPI Spends HK$14.986 Million to Buy Back 1.897 Million Shares on October 2
Stock News  ·  10-02
XTALPI Spends HK$14.986 Million to Buy Back 1.897 Million Shares on October 2
No data available

Introduction

Company Name.
XTALPI
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
XtalPi Holdings Ltd is a holding company primarily engaged in the provision of drug and material science research and development solutions and services in the pharmaceutical and material science industries. The Company mainly operates two businesses. Drug discovery solutions primarily encompass the development of early-stage lead compounds and investigational new drugs, providing research support for clinical trial initiation. Intelligent robotics solutions primarily include solid-state research and development services and automated chemical synthesis services. The Company conducts its business in the domestic and overseas markets.
Issue price:
--